ritonavir film coated
Generic: ritonavir 100 mg
Labeler: cipla usa inc.Drug Facts
Product Profile
Brand Name
ritonavir film coated
Generic Name
ritonavir 100 mg
Labeler
cipla usa inc.
Dosage Form
TABLET
Routes
Active Ingredients
ritonavir 100 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
69097-655
Product ID
69097-655_eeb20aab-f62a-4d80-92d1-2d6b3e2a5758
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA202573
Listing Expiration
2026-12-31
Marketing Start
2022-03-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
69097655
Hyphenated Format
69097-655
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ritonavir film coated (source: ndc)
Generic Name
ritonavir 100 mg (source: ndc)
Application Number
ANDA202573 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 100 mg/1
Packaging
- 30 TABLET in 1 CONTAINER (69097-655-02)
- 120 TABLET in 1 CONTAINER (69097-655-08)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "eeb20aab-f62a-4d80-92d1-2d6b3e2a5758", "openfda": {"nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "upc": ["0369097655082", "0369097655020"], "unii": ["O3J8G9O825"], "rxcui": ["900575"], "spl_set_id": ["4633c6ba-168d-426f-acae-7843e167743a"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "manufacturer_name": ["Cipla USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 CONTAINER (69097-655-02)", "package_ndc": "69097-655-02", "marketing_start_date": "20220323"}, {"sample": false, "description": "120 TABLET in 1 CONTAINER (69097-655-08)", "package_ndc": "69097-655-08", "marketing_start_date": "20220323"}], "brand_name": "Ritonavir film coated", "product_id": "69097-655_eeb20aab-f62a-4d80-92d1-2d6b3e2a5758", "dosage_form": "TABLET", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 3A Inhibitor [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inducers [MoA]"], "product_ndc": "69097-655", "generic_name": "ritonavir 100 mg", "labeler_name": "Cipla USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ritonavir", "brand_name_suffix": "film coated", "active_ingredients": [{"name": "RITONAVIR", "strength": "100 mg/1"}], "application_number": "ANDA202573", "marketing_category": "ANDA", "marketing_start_date": "20220323", "listing_expiration_date": "20261231"}